Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004955102 | SCV005495721 | uncertain significance | Inborn genetic diseases | 2024-08-01 | criteria provided, single submitter | clinical testing | The c.2262C>G (p.H754Q) alteration is located in exon 16 (coding exon 14) of the SETD5 gene. This alteration results from a C to G substitution at nucleotide position 2262, causing the histidine (H) at amino acid position 754 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |